Soolantra and Hydroxyzine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Soolantra (ivermectin) and Hydroxyzine (hydroxyzine hydrochloride). Common drug interactions include headache among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Soolantra and Hydroxyzine. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Soolantra?

Soolantra has active ingredients of ivermectin. eHealthMe is studying from 1,068 Soolantra users. Check the latest studies of Soolantra.

What is Hydroxyzine?

Hydroxyzine has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 54,069 Hydroxyzine users. Check the latest studies of Hydroxyzine.



On Jul, 17, 2026

31 people who take Soolantra and Hydroxyzine together, and have interactions are studied.

Soolantra and Hydroxyzine drug interactions.

What are the common drug interactions of Soolantra and Hydroxyzine, by gender? *:

female:

  1. Headache (pain in head)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Meningitis aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed)
  4. Subclavian vein thrombosis (abnormal condition in which a clot develops within the subclavian or axillary vein)
  5. Sinusitis (inflammation of sinus)
  6. Upper respiratory tract infection
  7. Influenza
  8. Fatigue (feeling of tiredness)
  9. Gastrointestinal viral infection (virus infection of gastrointestinal tract)
  10. Abnormal dreams

male:

  1. Chronic kidney disease
  2. Osteonecrosis (death of bone)
  3. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  4. Dry eye (lack of adequate tears)
  5. Dry skin
  6. Hand fracture
  7. Injection site pruritus (severe itching at injection site)
  8. Injection site swelling
  9. Rosacea (a skin condition that causes facial redness)
  10. Sinusitis (inflammation of sinus)

What are the common drug interactions of Soolantra and Hydroxyzine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Headache (pain in head)
  3. Meningitis aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed)
  4. Sinusitis (inflammation of sinus)
  5. Subclavian vein thrombosis (abnormal condition in which a clot develops within the subclavian or axillary vein)
  6. Upper respiratory tract infection
  7. Gastrointestinal viral infection (virus infection of gastrointestinal tract)
  8. Influenza
  9. Staphylococcal infection (an infection with staphylococcus bacteria)
  10. Urinary tract infection

40-49:

  1. Chronic kidney disease
  2. Osteonecrosis (death of bone)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Blood creatinine increased
  5. Bone density decreased
  6. Emotional distress
  7. Erythema (redness of the skin)
  8. Hip arthroplasty
  9. Pain
  10. Renal impairment (severely reduced kidney function)

50-59:

  1. Abnormal dreams
  2. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  3. Dizziness
  4. Dry eye (lack of adequate tears)
  5. Dry mouth
  6. Fall
  7. Fatigue (feeling of tiredness)
  8. Headache (pain in head)
  9. Hypersomnia (excessive daytime sleepiness (eds))
  10. Influenza

60+:

  1. Sinusitis (inflammation of sinus)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 8 people, 25.81%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 19.35%
  3. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 6 people, 19.35%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 12.90%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 9.68%
  6. Lichen Myxoedematosus (deposition of acid mucopolysaccharides in the skin): 3 people, 9.68%
  7. Irritable Bowel Syndrome: 2 people, 6.45%
  8. Hiv Infection: 2 people, 6.45%
  9. Drowsiness: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Soolantra and Hydroxyzine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Soolantra and Hydroxyzine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Soolantra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydroxyzine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Soolantra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxyzine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ivermectin and hydroxyzine hydrochloride (the active ingredients of Soolantra and Hydroxyzine, respectively), and Soolantra and Hydroxyzine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: